SGRY

Surgery Partners Inc.

Price

$13.19

return (12m)

-37.64%

p/e

-19.18

p/bv

0.55

DIVIDEND YIELD

0.00%

SGRY price

Surgery Partners

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SGRY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.21%

3 months

-22.91%

1 year

-37.64%

2 years

-57.71%

5 years

-69.35%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SGRY

Valuation

P/E

-19.18

Sector 1.27

Industry 8.57

P/BV

0.55

Sector 1.88

Industry 3.63

P/Revenue (PSR)

0.50

Sector 1.56

Industry 3.09

EV/EBITDA

36.29

Sector -46.85

Industry -17.98

EV/EBIT

50.25

Sector -51.35

Industry -94.21

P/EBITDA

3.03

Sector -31.66

Industry 7.07

P/EBIT

4.43

Sector -43.19

Industry -32.11

P/Total Assets

0.21

Sector 0.87

Industry 1.32

P/Net Current Assets

-0.49

Sector -26.04

Industry -3.44

P/Working Capital

3.10

Sector -4.00

Industry 7.65

EPS

-0.69

Sector -0.70

Industry -0.23

BVPS

24.08

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

22.51%

Sector 49.44%

Industry 55.16%

EBITDA Margin

16.66%

Sector -282.02%

Industry -13.47%

EBIT Margin

12.03%

Sector -164.03%

Industry -25.89%

Operating Margin

11.40%

Sector -19.60%

Industry -5.67%

Net Profit Margins

-2.63%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.11

Sector 0.13

Industry 0.13

Profitability

ROE

-2.86%

Sector -23.80%

Industry -24.00%

ROA

-1.10%

Sector -24.22%

Industry -5.96%

ROIC

5.78%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.95

Sector 1.90

Industry 2.56

Net Debt / EBITDA

24.27

Sector -23.34

Industry 9.41

Net Debt / EBIT

33.61

Sector -11.26

Industry -2.82

Net Debt / Equity

1.11

Sector -0.63

Industry -0.19

Gross Debt / Equity

1.18

Sector -0.73

Industry 0.42

Equity/Assets

0.39

Sector 0.46

Industry 0.50

Liabilities/Assets

0.57

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

8.63%

Sector -

Industry -

5Y Earnings CAGR

4.56%

Sector -

Industry -

Fundamentals SGRY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SGRY Surgery Partners Inc.	$13.19	-37.74%	0.00%	-19.18	0.55	-2.86%	-2.63%
JNJ Johnson & Johnson	$255.81	40.61%	2.06%	29.27	7.25	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$395.40	-9.73%	0.00%	44.62	7.65	17.15%	28.44%
CVS CVS Health Corporation	$86.67	17.21%	3.09%	22.49	1.38	6.12%	1.18%
HCA HCA Healthcare Inc.	$428.58	1.07%	0.71%	13.82	-29.45	-213.15%	8.77%
FMS Fresenius Medical Care AG & Co.	$22.22	-14.18%	2.75%	10.91	0.77	7.01%	4.84%
HUM Humana Inc.	$383.17	57.86%	0.93%	35.89	2.38	6.63%	0.88%
DVA DaVita Inc.	$179.11	34.80%	0.00%	13.69	-24.07	-175.83%	6.05%
WTW Weight Watchers International, Inc	$287.72	-15.06%	1.31%	17.23	3.47	20.14%	15.49%
LH Laboratory Corporation of America Holdings	$305.47	10.58%	0.94%	24.90	2.89	11.62%	6.99%
ALHC Alignment Healthcare Inc.	$7.91	-52.97%	0.00%	42.52	6.53	15.35%	0.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SGRY - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Surgery Partners

Surgery Partners Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2015

Time since IPO - 11 years

10.800

Employees

Surgery Partners Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.70 billion, with shareholders equity totaling $3.10 billion.

The company employs approximately 10.800 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Surgery Partners Inc. reported $3.37 billion in revenue, generating net income of $-88.60 million.

Key financial metrics include a P/E ratio of -19.18, a price-to-book (P/B) ratio of 0.55, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SGRY.

Market cap

$1.70 billion

Net worth

$3.10 billion

$3,101,700,000.00

Assets

$8.05 billion

$8,049,700,000.00

Total Shares Outstanding

128.83 million

128,825,000

Average Daily Trading Volume

$2.41 million

$2,409,770.36

Sector

Health

Industry

Health Services and Providers

SGRY

SGRY revenue and profits

Financial Results SGRY

DRAG THE FRAME TO SEE MORE DATA

SGRY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45